BioXcel Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New Haven, CT
SEC filing record 1 source field available
Fiscal year end
31 December
BioXcel Therapeutics, Inc. has filed 656 SEC EDGAR filings since 13 Nov 2017

SEC filing history

Showing 576-600 of 656 matching filings.

Per page
25
Current page
24
8-K File 001-38410

8-K

Filing date
11 Feb 2019
Reporting date
11 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

8-K

Filing date
04 Feb 2019
Reporting date
04 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90437

SC 13G/A filing

Filing date
10 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

8-K

Filing date
03 Jan 2019
Reporting date
03 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

8-K

Filing date
27 Dec 2018
Reporting date
27 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

8-K

Filing date
20 Dec 2018
Reporting date
19 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-38410

CT ORDER filing

Filing date
20 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Dec 2018
Reporting date
14 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

8-K

Filing date
12 Dec 2018
Reporting date
12 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

8-K

Filing date
12 Dec 2018
Reporting date
12 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Dec 2018
Reporting date
04 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Dec 2018
Reporting date
03 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Dec 2018
Reporting date
04 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Dec 2018
Reporting date
03 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Dec 2018
Reporting date
03 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Nov 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Nov 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Nov 2018
Reporting date
29 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Nov 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Nov 2018
Reporting date
29 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Nov 2018
Reporting date
29 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

8-K

Filing date
14 Nov 2018
Reporting date
14 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

8-K

Filing date
09 Nov 2018
Reporting date
09 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .